Neoantigenics is a liability company that focuses on developing oncology theranostics. These neoantigens are uniquely expressed in a wide range of urogenital tract cancers – ovarian, uterine, bladder, and renal cancers – as well as certain other solid cancers such as aggressive stages of pancreatic cancer and many head-and-neck cancers.

It was